{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=68387L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=68387L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=5089L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5089L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5089L,Language='DE')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=5089L,Language='DE')/Subjects"}},"ID":"5089","Language":"DE","MeetingNumber":11,"IdSession":5209,"SessionNumber":9,"SessionName":"Sommersession 2025","Council":1,"CouncilName":"Nationalrat","CouncilAbbreviation":"NR","Date":"\/Date(1750032000000)\/","Begin":"1430","Modified":"\/Date(1753301512753)\/","LegislativePeriodNumber":52,"PublicationStatus":"final","MeetingOrderText":"Elfte Sitzung","SortOrder":11,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20257511,IdSubject=68387L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20257511,IdSubject=68387L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20257511,IdSubject=68387L,Language='DE')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20257511,IdSubject=68387L,Language='DE')/Businesses"}},"IdSubject":"68387","BusinessNumber":20257511,"Language":"DE","BusinessShortNumber":"25.7511","Title":"Besorgniserregende Entwicklung bei codeinhaltigen Medikamenten. Welche Vorsichts- und Regulierungsmassnahmen sind vorgesehen?","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1749807606090)\/","TitleDE":"Fragestunde.\nFrage Crottaz Brigitte.\nBesorgniserregende Entwicklung\nbei codeinhaltigen Medikamenten.\nWelche Vorsichts- und\nRegulierungsmassnahmen\nsind vorgesehen?","TitleFR":"Heure des questions.\nQuestion Crottaz Brigitte.\nEvolution inqui\u00e9tante autour\ndes m\u00e9dicaments contenant\nde la cod\u00e9ine. Quelles mesures\nde pr\u00e9caution et de r\u00e9gulation\nsont-elles envisag\u00e9es ?","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=358732L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=358732L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=358732L,Language='DE')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=358732L,Language='DE')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=358732L,Language='DE')/Businesses"}},"ID":"358732","Language":"DE","IdSubject":"68387","VoteId":null,"PersonNumber":null,"Type":3,"Text":"<pd_text><p><i>Schriftliche Antwort (Beilage) - R\u00e9ponse \u00e9crite (annexe)</i></p>\n<p>[VS]</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20250616","MeetingVerbalixOid":4032,"IdSession":"5209","SpeakerFirstName":null,"SpeakerLastName":null,"SpeakerFullName":"","SpeakerFunction":null,"CouncilId":null,"CouncilName":null,"CantonId":null,"CantonName":null,"CantonAbbreviation":null,"ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":null,"End":null,"Function":null,"DisplaySpeaker":null,"LanguageOfText":"DE","Modified":"\/Date(1788981567957)\/","StartTimeWithTimezone":null,"EndTimeWithTimezone":null,"VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"68387","Language":"DE","IdMeeting":"5089","VerbalixOid":777104,"SortOrder":88,"Modified":"\/Date(1788981567955)\/"}}